Chan Henry Lee insider trades: BeOne Medicines (ONC) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Chan reports to the SEC
Open-market buys and sales
25 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | ONC | ↓ Sell | 1,115 | $375.00 | $418K | Direct | Oct 2, 2026 (2d) |
| Aug 11, 2026 | ONC | ↓ Sell | 2,666 | $360.00 | $960K | Direct | Aug 13, 2026 (2d) |
| Jul 30, 2026 | ONC | ↓ Sell | 1,044 | $323.69 | $338K | Direct | Aug 3, 2026 (4d) |
| Jul 22, 2026 | ONC | ↓ Sell | 1,669 | $325.00 | $542K | Direct | Jul 24, 2026 (2d) |
| Jul 8, 2026 | ONC | ↓ Sell | 664 | $302.46 | $201K | Direct | Jul 10, 2026 (2d) |
| Jun 16, 2026 | ONC | ↓ Sell | 590 | $265.98 | $157K | Direct | Jun 18, 2026 (2d) |
| Jun 11, 2026 | ONC | ↓ Sell | 428 | $257.63 | $110K | Direct | Jun 15, 2026 (4d) |
| Jun 8, 2026 | ONC | ↓ Sell | 871 | $270.42 | $236K | Direct | Jun 10, 2026 (2d) |
| May 13, 2026 | ONC | ↓ Sell | 332 | $310.72 | $103K | Direct | May 15, 2026 (2d) |
| Apr 8, 2026 | ONC | ↓ Sell | 332 | $311.59 | $103K | Direct | Apr 10, 2026 (2d) |
| Feb 4, 2026 | ONC | ↓ Sell | 1,660 | $349.52 | $580K | Direct | Feb 6, 2026 (2d) |
| Dec 11, 2025 | ONC | ↓ Sell | 664 | $321.64 | $214K | Direct | Dec 12, 2025 (1d) |
| Nov 12, 2025 | ONC | ↓ Sell | 996 | $349.17 | $348K | Direct | Nov 14, 2025 (2d) |
| Oct 8, 2025 | ONC | ↓ Sell | 10,671 | $350.40 | $3.7M | Direct | Oct 10, 2025 (2d) |
| Sep 10, 2025 | ONC | ↓ Sell | 10,006 | $325.53 | $3.3M | Direct | Sep 12, 2025 (2d) |
| Aug 13, 2025 | ONC | ↓ Sell | 11,013 | $300.45 | $3.3M | Direct | Aug 15, 2025 (2d) |
| Jul 30, 2025 | ONC | ↓ Sell | 920 | $304.60 | $280K | Direct | Jul 31, 2025 (1d) |
| Jun 16, 2025 | ONC | ↓ Sell | 422 | $266.50 | $112K | Direct | Jun 18, 2025 (2d) |
| Jun 6, 2025 | ONC | ↓ Sell | 700 | $256.11 | $179K | Direct | Jun 10, 2025 (4d) |
| Feb 27, 2025 | BGNE | ↓ Sell | 1,205 | $275.00 | $331K | Direct | Mar 3, 2025 (4d) |
| Feb 21, 2025 | BGNE | ↓ Sell | 1,202 | $258.04 | $310K | Direct | Feb 25, 2025 (4d) |
| Sep 30, 2024 | BGNE | ↓ Sell | 1,202 | $237.10 | $285K | Direct | Oct 2, 2024 (2d) |
| Jul 30, 2024 | BGNE | ↓ Sell | 834 | $160.57 | $134K | Direct | Aug 1, 2024 (2d) |
| Jun 17, 2024 | BGNE | ↓ Sell | 439 | $159.35 | $70K | Direct | Jun 20, 2024 (3d) |
| Jul 31, 2023 | BGNE | ↓ Sell | 791 | $216.26 | $171K | Direct | Aug 2, 2023 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ONC insiders
Open-market trades in the last 12 months
About Chan Henry Lee's insider trades
Chan Henry Lee is SVP, General Counsel at BeOne Medicines (ONC). Since Jul 31, 2023, Chan has reported no open-market purchases and 25 sales worth $16.5M on SEC Form 4. In the last 12 months: 13 sales ($4.3M).
Their filings also include option exercises (11 filings), grants and awards (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ONC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.